F. Bert

1.3k total citations
27 papers, 930 citations indexed

About

F. Bert is a scholar working on Molecular Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, F. Bert has authored 27 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Medicine, 9 papers in Infectious Diseases and 8 papers in Epidemiology. Recurrent topics in F. Bert's work include Antibiotic Resistance in Bacteria (12 papers), Bacterial Identification and Susceptibility Testing (8 papers) and Streptococcal Infections and Treatments (6 papers). F. Bert is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Bacterial Identification and Susceptibility Testing (8 papers) and Streptococcal Infections and Treatments (6 papers). F. Bert collaborates with scholars based in France, United States and Egypt. F. Bert's co-authors include N Lambert-Zechovsky, Catherine Branger, B. Bruneau, P J Berry, Richard Moreau, François Durand, Jacques Belghiti, M.‐H. Nicolas‐Chanoine, Véronique Leflon‐Guibout and Jacques‐Olivier Galdbart and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

F. Bert

26 papers receiving 883 citations

Peers

Countries citing papers authored by F. Bert

Since Specialization

Citations

This map shows the geographic impact of F. Bert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Bert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Bert more than expected).

Fields of papers citing papers by F. Bert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Bert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Bert. The network helps show where F. Bert may publish in the future.

Co-authorship network of co-authors of F. Bert

This figure shows the co-authorship network connecting the top 25 collaborators of F. Bert. A scholar is included among the top collaborators of F. Bert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Bert. F. Bert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Faecal carriage of extended-spectrumβ-lactamase (ESBL)-producing enterobacteria in liver disease patients from two hospitals in Egypt and France: a comparative epidemiological study 2014 ·Epidemiology and Infection ·(unknown), (unknown), F. Bert, Véronique Leflon‐Guibout, (unknown), Maged El-Ghannam, (unknown), Mahmoud Omar, (unknown), Dominique Valla, M.‐H. Nicolas‐Chanoine	14
2	10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum -lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre 2012 ·Journal of Antimicrobial Chemotherapy ·Marie-Hélène Nicolas-Chanoine, (unknown), Suzanne Bialek-Davenet, Xavier Bertrand, (unknown), F. Bert, Mati Moyat, (unknown), Estelle Marcon, (unknown), Latifa Noussair, Richard Moreau, Véronique Leflon‐Guibout	126
3	Molecular epidemiology of Escherichia coli bacteremia in liver transplant recipients 2011 ·Transplant Infectious Disease ·F. Bert, (unknown), Fédérica Dondero, James R. Johnson, Cathérine Paugam‐Burtz, François Durand, Jacques Belghiti, Dominique Valla, Richard Moreau, M.‐H. Nicolas‐Chanoine	10
4	Microbiological findings of culture‐positive preservation fluid in liver transplantation 2010 ·Transplant Infectious Disease ·Sylvie Janny, F. Bert, Fédérica Dondero, François Durand, (unknown), P. Merckx, M.‐H. Nicolas‐Chanoine, Jacques Belghiti, Jean Mantz, Cathérine Paugam‐Burtz	30
5	Genetic background of Escherichia coli isolates from patients with spontaneous bacterial peritonitis: relationship with host factors and prognosis 2008 ·Clinical Microbiology and Infection ·F. Bert, Xavière Panhard, James R. Johnson, Hervé Lécuyer, Richard Moreau, (unknown), (unknown), (unknown), Dominique Valla, M.‐H. Nicolas‐Chanoine	21
6	Émergence d’entérocoque dépendant de la vancomycine à la suite d’un traitement par glycopeptide : cas clinique et revue 2008 ·Pathologie Biologie ·F. Bert, Véronique Leflon‐Guibout, (unknown), Nancy Bourdon, M.‐H. Nicolas‐Chanoine	9
7	Évaluation de l'antibiogramme par diffusion en milieu gélosé pour le dépistage de souches de Clostridium difficile de sensibilité diminuée aux antibiotiques 2007 ·Pathologie Biologie ·I. Poîlane, F. Bert, P. Cruaud, M.‐H. Nicolas‐Chanoine, Anne Collignon	13
8	Nosocomial and Community-Acquired Spontaneous Bacterial Peritonitis: Comparative Microbiology and Therapeutic Implications 2003 ·European Journal of Clinical Microbiology & Infectious Diseases ·F. Bert, M. Andreu, François Durand, Françoise Degos, Jacques‐Olivier Galdbart, Richard Moreau, Catherine Branger, N Lambert-Zechovsky, Dominique Valla	48
9	Pseudomonas aeruginosa : actualités sur la résistance aux b-lactamines et implications thérapeutiques 2000 ·F. Bert, N Lambert-Zechovsky	2
10	Association between Nasal Carriage of Staphylococcus Aureus and Infection in Liver Transplant Recipients 2000 ·Clinical Infectious Diseases ·F. Bert, Jacques‐Olivier Galdbart, Virginie Zarrouk, J. Le Mée, François Durand, France Mentré, Jacques Belghiti, N Lambert-Zechovsky, B. Fantin	56
11	Multi-resistant Pseudomonas aeruginosa outbreak associated with contaminated tap water in a neurosurgery intensive care unit 1998 ·Journal of Hospital Infection ·F. Bert, (unknown), B. Bruneau, P J Berry, N Lambert-Zechovsky	148
12	Pulsed-Field Gel Electrophoresis Is More Discriminating Than Multilocus Enzyme Electrophoresis and Random Amplified Polymorphic DNA Analysis for Typing Pyogenic Streptococci 1997 ·Current Microbiology ·F. Bert, Catherine Branger, N Lambert-Zechovsky	64
13	Analysis of a case of recurrent bacteraemia due to group AStreptococcus equisimilis by pulsed-field gel electrophoresis 1997 ·Infection ·F. Bert, N Lambert-Zechovsky	15
14	A case of bacteremia caused byStreptococcus dysgalactiae 1997 ·European Journal of Clinical Microbiology & Infectious Diseases ·F. Bert, N Lambert-Zechovsky	7
15	Activities of Piperacillin, Ceftazidime, Cefepime and Cefpirome against <i>Pseudomonas aeruginosa</i> Strains with Intrinsic Ticarcillin Resistance 1996 ·Chemotherapy ·F. Bert, (unknown), N Lambert-Zechovsky, Catherine Branger	1
16	Analysis of genetic relationships among strains of groups A, C and G streptococci by random amplified polymorphic DNA analysis 1996 ·Journal of Medical Microbiology ·F. Bert, Bertrand Picard, Catherine Branger, N Lambert-Zechovsky	14
17	Sinusitis in mechanically ventilated patients and its role in the pathogenesis of nosocomial pneumonia 1996 ·European Journal of Clinical Microbiology & Infectious Diseases ·F. Bert, N Lambert-Zechovsky	41
18	[Comparison of the activity of beta-lactams against Pseudomonas aeruginosa according to phenotypes of resistance]. 1996 ·PubMed ·F. Bert, (unknown), Catherine Branger, N Lambert-Zechovsky	4
19	Identification and typing of pyogenic streptococci by enzyme electrophoretic polymorphism 1995 ·Journal of Medical Microbiology ·F. Bert, Bertrand Picard, N Lambert-Zechovsky, P Goullet	7
20	[Epidemiological studies of the susceptibility of Pseudomonas aeruginosa to antibiotics]. 1994 ·PubMed ·F. Bert, B. Bruneau, N Lambert-Zechovsky, Catherine Branger	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact